Risk Factors
114 articles
Researching More Second-Line Options for Pancreatic Cancer
Dr. Allyson Ocean explains the concept behind a novel second-line treatment being tested for metastatic pancreatic cancer.
A Story that Began During COVID-19, with a Preview Seven Years Before
Penelope Dixon has gone through many treatments for her pancreatic cancer because of recurrences, but she has not given up.
Felix 2.0 Builds Upon Artificial Intelligence Earlier Detection Successes
Can artificial intelligence help find pancreatic cancer sooner? Dr. Elliot Fishman thinks so, and has been working to make it happen.
Should Cancer Patients Get the COVID-19 Vaccine? Yes!
Should pancreatic cancer patients get the COVID-19 vaccine? According to the experts, yes, and as soon as they can.
Confused about COVID-19 Testing? What You Need to Know
Confused by the information about COVID-19 testing? Our article explains the types of tests, whether testing is readily available, and how to get tested.
Identifying Biomarkers for Early Detection of Pancreatic Cancer
A clinical trial for at-risk people is looking for biomarkers that can indicate pancreatic cancer is growing.
Don’t Stop Fighting
Leonora Kaufmann relied on her instinct about pancreatic cancer. Diagnosis at stage I has given her a fighting chance of survival.
Tailoring My Treatment to My Tumor Genetics
After diagnosis with pancreatic cancer, Sharon Simone had her tumor analyzed. The report on her tumor genetics determined her treatment.
Important Questions When Starting Pancreatic Cancer Treatment
Dr. Gauri Varadhachary outlines the important questions to ask when you start treatment with surgery, chemotherapy, or radiation for pancreatic cancer.
The SHARON Trial
Long-term survivor Sharon Seibel is one of very few to have a clinical trial named for her, thanks to her brother, a cancer researcher.
Gathering Information for the Right Treatment
Staci and Rich Grodin applied their medical information research skills when Rich was diagnosed with pancreatic cancer.
A Potential Role for PARP Inhibitors in Pancreatic Cancer
Dr. Michael Pishvaian leads research into the possible role of PARP inhibitors in treating pancreatic cancer patients with certain genetic mutations.
COVID-19 and Pancreatic Cancer Clinical Trials
How is the COVID-19 pandemic affecting clinical trials? Learn more about what steps are being taken to protect patients on trials, plus more.
Resources
Our extensive collection of web-based and other resources for patients, families, and caregivers provides easy access to information on a wide variety of subjects related to pancreatic cancer. The resources are reviewed and updated periodically to ensure they are current.
I Want to Live!
Every day long-term survivor of pancreatic cancer Doron Bromon sends an important message to the world: I Want to Live!